{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:38:40Z","timestamp":1774485520559,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22183MFDS443"],"award-info":[{"award-number":["22183MFDS443"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["HV23C0074"],"award-info":[{"award-number":["HV23C0074"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["HV22C0263"],"award-info":[{"award-number":["HV22C0263"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korean Health Technology R&amp;D Project","award":["22183MFDS443"],"award-info":[{"award-number":["22183MFDS443"]}]},{"name":"Korean Health Technology R&amp;D Project","award":["HV23C0074"],"award-info":[{"award-number":["HV23C0074"]}]},{"name":"Korean Health Technology R&amp;D Project","award":["HV22C0263"],"award-info":[{"award-number":["HV22C0263"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Japanese encephalitis (JE) is a very severe disease characterized by high fatality rates and the development of permanent behavioral, psychiatric, and neurological sequelae among survivors. Japanese encephalitis virus (JEV), a flavivirus, is responsible for JE. In Asia, Genotype I (GI) has emerged as the dominant strain, replacing Genotype III (GIII). However, no clinically approved drug is available to treat JEV infection, and currently available commercial vaccines derived from JEV GIII strains provide only partial protection against GI. Utilizing a reverse genetics system, this study attempted to produce a novel chimeric JEV strain with high efficacy against JEV GI. Accordingly, a GI\/GIII intertypic recombinant strain, namely SA14-GI env, was generated by substituting the E region of the GIII SA14-14-2 strain with that of the GI strain, K05GS. The neurovirulence of the mutant virus was significantly reduced in mice. Analysis of the immunogenicity of the chimeric virus revealed that it induced neutralizing antibodies against JEV GI in mice, and the protective efficacy of SA14-GI env was higher than that of SA14-14-2. These findings suggest that SA14-GI env may be a safe and effective live-attenuated vaccine candidate against JEV GI.<\/jats:p>","DOI":"10.3390\/vaccines11121827","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T03:03:33Z","timestamp":1702004613000},"page":"1827","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Attenuated Chimeric GI\/GIII Vaccine Candidate against Japanese Encephalitis Virus"],"prefix":"10.3390","volume":"11","author":[{"given":"Eunji","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1681-5557","authenticated-orcid":false,"given":"Young Bong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Khare, B., and Kuhn, R.J. (2022). The Japanese Encephalitis Antigenic Complex Viruses: From Structure to Immunity. Viruses, 14.","DOI":"10.3390\/v14102213"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s13365-014-0285-z","article-title":"Flaviviruses, an expanding threat in public health: Focus on dengue, West Nile, and Japanese encephalitis virus","volume":"20","author":"Daep","year":"2014","journal-title":"J. Neurovirol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e51027","DOI":"10.7554\/eLife.51027","article-title":"Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000\u20132015","volume":"9","author":"Quan","year":"2020","journal-title":"eLife"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sanborn, M.A., Wuertz, K.M., Heung-Chul, K., Yang, Y., Li, T., Pollett, S.D., Jarman, R.G., Berry, I.M., Klein, T.A., and Hang, J. (2021). Identification of Japanese Encephalitis Virus Genotype V and Other Mosquito-borne Viruses in Camp Humphreys, Republic of Korea, using Metagenomic Analysis. bioRxiv.","DOI":"10.1101\/2021.03.15.435489"},{"key":"ref_5","unstructured":"World Health Organization (2023, May 08). Japanese Encephalitis. Global Health Observatory Data Repository. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/japanese-encephalitis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chen, H.Y., Yang, C.Y., Hsieh, C.Y., Yeh, C.Y., Chen, C.C., Chen, Y.C., Lai, C.C., Harris, R.C., Ou, H.T., and Ko, N.Y. (2021). Long-term neurological and healthcare burden of adults with Japanese encephalitis: A nationwide study 2000\u20132015. PLoS Neglected Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009703"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: A systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"ref_8","first-page":"e38455","article-title":"A Profile Study of Japanese Encephalitis in an Industrial Hospital in Eastern India","volume":"15","author":"Kamath","year":"2023","journal-title":"Cureus"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wahaab, A., Mustafa, B.E., Hameed, M., Stevenson, N.J., Anwar, M.N., Liu, K., Wei, J., Qiu, Y., and Ma, Z. (2021). Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review. Viruses, 14.","DOI":"10.3390\/v14010044"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JVI.06072-11","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14712598.8.1.95","article-title":"Current use and development of vaccines for Japanese encephalitis","volume":"8","author":"Beasley","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1080\/21645515.2017.1285472","article-title":"Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease","volume":"13","author":"Hegde","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11262-019-01674-y","article-title":"Development of a reverse genetics system for Japanese encephalitis virus strain SA14-14-2","volume":"55","author":"Li","year":"2019","journal-title":"Virus Genes"},{"key":"ref_14","first-page":"1105","article-title":"Misincorporation by RNA polymerase is a major source of transcription pausing in vivo","volume":"45","author":"James","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1128\/JVI.77.11.6450-6465.2003","article-title":"Development and application of a reverse genetics system for Japanese encephalitis virus","volume":"77","author":"Yun","year":"2003","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICTV Virus Taxonomy Profile: Flaviviridae","volume":"98","author":"Simmonds","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4014\/jmb.2207.07002","article-title":"Emerging Japanese Encephalitis Virus Genotype V in Republic of Korea","volume":"32","author":"Lee","year":"2022","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijbiomac.2022.07.027","article-title":"A review on Japanese Encephalitis virus emergence, pathogenesis and detection: From conventional diagnostics to emerging rapid detection techniques","volume":"217","author":"Mohsin","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1128\/JVI.00219-15","article-title":"Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice","volume":"89","author":"Gromowski","year":"2015","journal-title":"J. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1038\/ncomms10832","article-title":"Vector-free transmission and persistence of Japanese encephalitis virus in pigs","volume":"7","author":"Ricklin","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tajima, S., Taniguchi, S., Nakayama, E., Maeki, T., Inagaki, T., Saijo, M., and Lim, C.K. (2021). Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV. Vaccines, 9.","DOI":"10.3390\/vaccines9101077"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hansen, C.A., and Barrett, A.D.T. (2021). The Present and Future of Yellow Fever Vaccines. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090891"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Su, C.L., Yang, C.F., Teng, H.J., Lu, L.C., Lin, C., Tsai, K.H., Chen, Y.Y., Chen, L.Y., Chang, S.F., and Shu, P.Y. (2014). Molecular epidemiology of Japanese encephalitis virus in mosquitoes in Taiwan during 2005\u20132012. PLoS Neglected Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003122"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gao, X., Liu, H., Wang, H., Fu, S., Guo, Z., and Liang, G. (2013). Southernmost Asia is the source of Japanese encephalitis virus (genotype 1) diversity from which the viruses disperse and evolve throughout Asia. PLoS Neglected Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002459"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12985-015-0278-4","article-title":"Molecular epidemiology of Japanese encephalitis in northern Vietnam, 1964\u20132011: Genotype replacement","volume":"12","author":"Do","year":"2015","journal-title":"Virol. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bsheal.2022.08.001","article-title":"Reverse Genetics in Virology: A Double Edged Sword","volume":"4","author":"Chen","year":"2022","journal-title":"Biosaf. Health"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105486","DOI":"10.1016\/j.antiviral.2022.105486","article-title":"Reverse genetic systems of SARS-CoV-2 for antiviral research","volume":"210","author":"Kurhade","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yun, S.I., Song, B.H., Kim, J.K., Yun, G.N., Lee, E.Y., Li, L., Kuhn, R.J., Rossmann, M.G., Morrey, J.D., and Lee, Y.M. (2014). A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: A conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004290"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Huang, R., Leng, S., Feng, Y., Tang, L., Yuan, L., and Yang, J. (2019). Chimeric Japanese Encephalitis Virus SA14\/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14. Can. J. Infect. Dis. Med. Microbiol., 2019.","DOI":"10.1155\/2019\/9179308"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-021-00371-y","article-title":"Japanese encephalitis virus live-attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity","volume":"6","author":"Davis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13238-018-0551-6","article-title":"The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism","volume":"10","author":"Liu","year":"2019","journal-title":"Protein Cell"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yang, J., Yang, H., Li, Z., Wang, W., Lin, H., Liu, L., Ni, Q., Liu, X., Zeng, X., and Wu, Y. (2017). Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain. Viruses, 9.","DOI":"10.3390\/v9010020"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00571925","article-title":"Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process","volume":"5","author":"Aihara","year":"1991","journal-title":"Virus Genes"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/12\/1827\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:35:03Z","timestamp":1760132103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/12\/1827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["vaccines11121827"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11121827","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]}}}